ENTITY
Abbott India

Abbott India (BOOT IN)

54
Analysis
Health CareIndia
Abbott India Limited manufactures a wide range of pharmaceutical and medical products, agrochemicals, and animal health products. The Company's medical and pharmaceutical products include insulin injections, anti-dysentery drugs, vitamin preparations, penicillin preparations, sulfonamide tablets, and a variety of household remedies.
more
Refresh
12 Oct 2022 00:16Broker

Pharma Q2fy23 Preview

The Pharma universe under our coverage could report aggregate Revenue/EBITDA/PAT growth of 5.6%/-4.8%/-2.2% YoY. Currency (Rs) has depreciated by 5.0%

Logo
145 Views
Share
08 Oct 2022 02:20Broker

Axis Research Scorecard Report - Sep 22

Axis Top Picks basket reported a resilient performance with an astounding return of 143% since its inception, notably beating an 84% return...

Logo
284 Views
Share
bullishAbbott India
12 Aug 2022 21:37Broker

Abbott India Ltd - Key Therapies Report Robust Sales Improvement

AIL reported revenue growth of 7.1% YoY in Q1FY23 (vs. our expectations of 8% YoY), outpacing the IPM* growth of 2.0% (IPM: Indian Pharma Industry,...

Logo
297 Views
Share
12 Apr 2022 17:23Broker

Pharma Q4FY22 Preview: Cost Pressure and Pricing Erosion Compress Margins

We expect companies under our Pharma coverage to report high singledigit growth (6.2% YoY), primarily driven by Injectable and Generic segment.

Logo
255 Views
Share
bullishAbbott India
11 Jan 2022 17:07Broker

Pick of the Week: Abbott India Ltd

Revenue growth of Abbott India Ltd (AIL) for FY21 has outpaced the Indian Pharma Market (IPM) growth by 100 bps majorily contributed by addition of...

Logo
193 Views
Share
x